Label | Id |
---|
clinical manifestations of COVID-19 | Condition | |
co morbid | Condition | |
co morbid conditions | Condition | |
independently | Condition | |
In vitro | Condition | |
in vitro | Condition | |
multiple co morbid conditions | Condition | |
On cells | Condition | |
symptomatic | Condition | |
Symptomatic presentation of COVID-19 | Condition | |
TxA2 increases significantly | Condition |